Lion Biotech Investors Sue Co. In Wake Of SEC Crackdown
Lion Biotechnologies was hit with a putative class action bringing securities fraud allegations in California federal court on Friday after it settled with the U.S. Securities and Exchange Commission to end...To view the full article, register now.
Already a subscriber? Click here to view full article